The advisor declined to issue the Inno-Gene analysis
published: today, 14-04-2021, 09:34
update: today, 04/14/2021, 13:13
–
–
– –
Best Capital, an authorized advisor on the NewConnect market, refused to issue a document of Inno-Gene’s economic, property and financial analysis.
The main reason for the refusal is the management board’s failure to publish the correction of the report for the fourth quarter of 2020, and thus the lack of current financial data for the preparation of a financial analysis.
–